Trial intelligence / Profile preview

Bupropion PK in Post-Bariatric Surgery

NCT02173886Phase 4Completed

Sponsor
North Dakota State University
Start
Jun 2014
Primary completion
Feb 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of bupropion in major depressive disorder (MDD), sponsored by North Dakota State University. Started Jun 2014; status: completed.

02

Drugs

bupropion
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT02173886.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02173886.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call